News

Teewinot Life Sciences' Irish Subsidiary, Full Spectrum Laboratories, Ltd. Secures a U.S. patent for the biosynthesis of cannabinoids.

Houston Methodist Hospital researchers have advanced a potential treatment for metaplastic breast cancer—the most aggressive subtype of triple negative breast cancer, into patients in just under four years.

New research has revealed the function of a widely shared enzyme component, the Zf-GRF domain, as a critical molecular tool necessary for manipulating DNA during repair processes.

A family of enzymes known as KDM5 are the subject of a recent Yale study, they have previously been shown to be involved in cancer cell growth.

HUB Organoid Technology's organoids are to enter a validation trial for their potential in identifying responding Cystic Fibrosis patients.

A new study led by scientists at The Scripps Research Institute (TSRI) is the first to show exactly how the drug Arbidol stops influenza infections. The research reveals that Arbidol stops the virus from entering host cells by binding within a recessed pocket on the virus.

Metabolon announced today that it has entered into an agreement with InnVentis Ltd. to apply metabolomics in individuals with chronic inflammatory diseases.

A modified malaria parasite worked as expected in its first, small human clinical trial.

Inhibiting MRTF pathway significantly reduces melanoma metastasis.

Pluripotent stem cells have been used to grow functional stomach and intestine tissues.